SV
Satish Verma
About Satish Verma
Data last updated:
Satish Verma is a Director at Kaansla Pharmaceuticals Private Limited (since 2020). The companies operate in Pharma. Kaansla Pharmaceuticals Private Limited reported revenue of ₹62.1 Lakh (FY 2025). Earlier, Satish Verma was a Director at Fealth Life Care Private Limited (2019–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kaansla Pharmaceuticals Private Limited U24239HR2020PTC091817 | Director | 24 Dec 2020 | 2020 | ₹62.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fealth Life Care Private Limited U51909HR2019PTC078069 | Director | 23 Jan 2019 | 2019 | ₹2.76 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satish Verma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Monika Verma | 09009481 | Kaansla Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satish Verma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satish Verma
Satish Verma currently holds 1 directorship: Kaansla Pharmaceuticals Private Limited (Director, since 24 Dec 2020, revenue ₹62.1 Lakh (FY 2025)).
Satish Verma was first appointed on 23 Jan 2019 as Director at Fealth Life Care Private Limited. The most recent appointment on record is 24 Dec 2020 at Kaansla Pharmaceuticals Private Limited.
Satish Verma held 1 earlier board appointment: Fealth Life Care Private Limited (Director, 23 Jan 2019 to 16 Jan 2021).
The current boards of Satish Verma's companies include Monika Verma (Kaansla Pharmaceuticals Private Limited).